Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults

State- and sex-specific prevalence of selected characteristics--Behavioral Risk Factor Surveillance System, 1996 and 1997.

Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110 · see citing works

Time-dependent covariates in the Cox proportional-hazards regression model.

Fisher, L., & Lin, D.-Y. (1999) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.20.1.145 · Cited by 1,055 · see citing works

The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine

Shapiro, E. D., Berg, A. T., AUSTRIAN, R. C., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,050 · see citing works

Community-Acquired Pneumonia

Bartlett, J. G., & Mundy, L. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332408 · Cited by 982 · see citing works

Incidence of Community-Acquired Pneumonia Requiring Hospitalization

Marston, B. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360129015 · Cited by 915 · see citing works

Increasing Prevalence of Multidrug-Resistant<i>Streptococcus pneumoniae</i>in the United States

Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888 · see citing works

Community-Acquired Pneumonia Requiring Hospitalization: 5-Year Prospective Study

Marrie, T. J., Durant, H., & Yates, L. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.4.586 · Cited by 644 · see citing works

Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia

BLACK, S. B., Shinefield, H. R., Ling, S. M., Hansen, J. R., FIREMAN, B. H., Spring, D. B., Noyes, J. F., Lewis, E. M., Ray, P., Lee, J., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200209000-00005 · Cited by 615 · see citing works

Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997

Feikin, D. R., Schuchat, A., KOLCZAK, M. S., Barrett, N. L., Harrison, L. H., Lefkowitz, L. B., McGeer, A., Farley, M. M., Vugia, D. J., Lexau, C., et al. (2000) · American Journal of Public Health · doi:10.2105/ajph.90.2.223 · Cited by 586 · see citing works

Hospitalized Community-acquired Pneumonia in the Elderly: Age- and Sex-related Patterns of Care and Outcome in the United States

Kaplan, V., Angus, D. C., Griffin, M. F., Clermont, G., Watson, R. S., & Linde‐Zwirble, W. T. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.6.2103038 · Cited by 561 · see citing works

23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

French, N., Nakiyingi, J., Carpenter, L., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02377-1 · Cited by 463 · see citing works

Efficacy of Pneumococcal Vaccine in High-Risk Patients

Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M. S., Baltch, A. L., Geiseler, P. J., Nadler, J. P., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 396 · see citing works

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people

Örtqvist, Å., Hedlund, J., Burman, L. Å., Elbel, E., Höfer, M., Leinonen, M., Lindblad, I., Sundelöf, B., & Kalin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07358-3 · Cited by 376 · see citing works

Efficacy of Pneumococcal Vaccination in Adults

Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 374 · see citing works

Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People

Sisk, J. E. (1997) · JAMA · doi:10.1001/jama.1997.03550160053038 · Cited by 355 · see citing works

Deaths: final data for 1999.

Hoyert, D. L., Arias, E., Smith, B. L., Murphy, S. L., & Kochanek, K. D. (2001) · PubMed · Cited by 338 · see citing works

The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease

Nichol, K. L., Baken, L., Wuorenma, J., & Nelson, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.20.2437 · Cited by 297 · see citing works

Immunization of Humans with Recombinant Pneumococcal Surface Protein A (rPspA) Elicits Antibodies That Passively Protect Mice from Fatal Infection withStreptococcus pneumoniaeBearing Heterologous PspA

Briles, D. E., Hollingshead, S. K., King, J. D., Swift, A. J., Braun, P. A., Park, M. K., Ferguson, L. M., Nahm, M. H., & Nabors, G. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/317602 · Cited by 261 · see citing works

Is Streptococcus Pneumoniae the leading cause of pneumonia of unknown etiology? a microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia

Ruiz-González, A., Falguera, M., Nogues, A., & Caballero, M. R. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00050-9 · Cited by 250 · see citing works

Clinical Efficacy of Pneumococcal Vaccine in the Elderly

Koivula, I., Stén, M., Leinonen, M., & Mäkelä, P. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00149-6 · Cited by 217 · see citing works

Pneumococcal Disease among Human Immunodeficiency Virus-Infected Persons: Incidence, Risk Factors, and Impact of Vaccination

Dworkin, M. S., Ward, J. W., Hanson, D. L., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/319218 · Cited by 211 · see citing works

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

Marston, B. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.15.1709 · Cited by 201 · see citing works

Evaluation of Effectiveness of the 23-Valent Pneumococcal Capsular Polysaccharide Vaccine for HIV-Infected Patients

Breiman, R. F., Keller, D. W., Phelan, M. A., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2633 · Cited by 172 · see citing works

Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials

Cornu, C., Yzebe, D., Léophonte, P., GAILLAT, J., Boissel, J., & Cucherat, M. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00217-1 · Cited by 166 · see citing works

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

Honkanen, P. O., Keistinen, T., Miettinen, L., Herva, E., Sankilampi, U., Läärä, E., Leinonen, M., Kivelä, S.-L., & Mäkelä, P. H. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00069-9 · Cited by 161 · see citing works

The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection

Briles, D. E., Hollingshead, S. K., Brooks-Walter, A., Nabors, G. S., Ferguson, L. M., Schilling, M. L., Gravenstein, S., Braun, P., King, J. D., & Swift, A. J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00511-3 · Cited by 148 · see citing works

Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data

Newschaffer, C. J., Bush, T. L., & Penberthy, L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00050-4 · Cited by 148 · see citing works

Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults

Watson, L. C., Wilson, B. J., & Waugh, N. R. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00112-3 · Cited by 130 · see citing works

Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials

Moore, R. A., Wiffen, P. J., & Lipsky, B. A. (2000) · BMC Family Practice · doi:10.1186/1471-2296-1-1 · Cited by 127 · see citing works

Misclassification and Selection Bias When Identifying Alzheimer's Disease Solely from Medicare Claims Records

Newcomer, R. J., Clay, T., Luxenberg, J. S., & Miller, R. H. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb04580.x · Cited by 125 · see citing works

[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].

GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115 · see citing works

Pneumococcal Infection and Immunologic Response to Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease

Davis, A. L., Aranda, C. P., Schiffman, G., & Christianson, L. C. (1987) · CHEST Journal · doi:10.1378/chest.92.2.204 · Cited by 103 · see citing works

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

Sisk, J. E. (1997) · JAMA · doi:10.1001/jama.278.16.1333 · Cited by 86 · see citing works

Influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.

Hay, A., Gust, I. D., Hampson, A. W., Nerome, K., Tashiro, M., Canas, L. C., Lavanchay, D., & Levandowski, R. A. (2000) · MMWR Morbidity and Mortality Weekly Report · Cited by 36 · see citing works

Capturing tobacco status using an automated billing system: steps toward a tobacco registry

McAfee, T. A., Grossman, R., Dacey, S., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210128009 · Cited by 23 · see citing works

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983 · see citing works

Untitled work

Hao (2015) · doi:10.1002/14651858 · Cited by 11,321 · see citing works

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary

Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925 · see citing works

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

Bonten, M. J. M., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven, C. H., van Deursen, A. M. M., Sanders, E. A. M., Verheij, T. J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408544 · Cited by 1,248 · see citing works

Respiratory risks from household air pollution in low and middle income countries

Gordon, S. B., Bruce, N. G., Grigg, J., Hibberd, P. L., Kurmi, O. P., Lam, K.-B. H., Mortimer, K., Asante, K. P., Balakrishnan, K., Balmes, J., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70168-7 · Cited by 953 · see citing works

. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Effros, R. B., Fletcher, C. V., Gebo, K., Halter, J. B., Hazzard, W. R., Horne, F. M., Huebner, R. E., Janoff, E. N., Justice, A. C., Kuritzkes, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590150 · Cited by 539 · see citing works

Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols

Bomar, L., Brugger, S. D., Yost, B. H., Davies, S. S., & Lemon, K. P. (2016) · mBio · doi:10.1128/mbio.01725-15 · Cited by 332 · see citing works

The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09.

MacIntyre, C. R., Chughtai, A. A., Barnes, M., Ridda, I., Seale, H., Toms, R., & Heywood, A. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3548-0 · Cited by 323 · see citing works

Respiratory viruses predisposing to bacterial infections: role of neuraminidase.

PELTOLA, V. T., & MCCULLERS, J. A. (2004) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000108197.81270.35 · Cited by 290 · see citing works

Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell

Shi, Y., Yamazaki, T., Okubo, Y., Uehara, Y., Sugane, K., & Agematsu, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.5.3262 · Cited by 229 · see citing works

How do viral infections predispose patients to bacterial infections?

Beadling, C., & Slifka, M. K. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200406000-00003 · Cited by 183 · see citing works

Immunological responses to pneumococcal vaccine in frail older people

Ridda, I., MacIntyre, C. R., Lindley, R., Gao, Z., Sullivan, J. S., Yuan, F. F., & McIntyre, P. B. (2009) · Vaccine · doi:10.1016/j.vaccine.2008.11.098 · Cited by 144 · see citing works

Premature ageing of the immune system underlies immunodeficiency in ataxia telangiectasia

Exley, A. R., Buckenham, S., Hodges, E., Hallam, R., Byrd, P., Last, J., Trinder, C., Harris, S., Screaton, N., Williams, A. P., et al. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.03.007 · Cited by 30 · see citing works

Pneumococcal vaccine in adults reduces the risk of infections caused by Streptococcus pneumoniae

Belocerkovskaja, Y. G., Romanovskih, A. G., & Алексеевна, С. Е. (2016) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2016-94-1-61-66 · Cited by 3 · see citing works

Rethinking results from the Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial

Gessner, B. D., Theilacker, C., & Jódar, L. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.040 · Cited by 8 · see citing works

Distribution and annual changes in the proportion of Streptococcus pneumoniae serotypes in Japanese adults with pneumococcal pneumonia from 2011 to 2017

Noguchi, S., Yatera, K., Akata, K., et al. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.07.007 · Cited by 9 · see citing works

Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older

Honkanen, P. O., Keistinen, T., Miettinen, L., Herva, E., Sankilampi, U., Läärä, E., Leinonen, M., Kivelä, S.-L., & Mäkelä, P. H. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00069-9 · Cited by 161 · see citing works

Pneumococcal polysaccharide vaccine prevents mortality after pneumonia in adults aged 60 – 79 years – a population based cohort study on more than 738.000 adults over 60 years

Kolditz, M., Schmitt, J. M., Pletz, M. W., et al. (2018) · Pneumologie · doi:10.1055/s-0037-1613661